Switch to
View more

Jagsonpal Pharmaceuticals Ltd

JAGSNPHARM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹766 cr, stock is ranked 1,080
High RiskStock is 3.90x as volatile as Nifty
310.2517.50 (+5.98%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹766 cr, stock is ranked 1,080
High RiskStock is 3.90x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
39.17
PB RatioPB Ratio
6.29
Dividend YieldDiv. Yield
1.37%
Sector PESector PE
32.92
Sector PBSector PB
4.57
Sector Div YldSctr Div Yld
0.97%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Jagsonpal Pharmaceuticals Limited is engaged in pharmaceutical business. It specializes in developing and manufacturing bulk drugs and pharmaceutical formulations.

Investor PresentationView older 

Feb 22, 2022

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2019202020212022168.26161.10192.34229.437.227.8817.0519.58
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 1.62%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

General updates 
Announced OnJun 27, 2022

Jagsonpal Pharmaceuticals Limited has informed the Exchange about Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 | Download

Jagsonpal Pharmaceuticals Limited has informed the Exchange about Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 | Download

Open Offer 
Announced OnJun 22, 2022

Centrum Capital Limited ('Manager to the Offer') has submitted to the Exchange a copy of Post offer advertisement in accordance with Regulation 18(12) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended, for the attention of the public shareholders of the Company. | Download

Centrum Capital Limited ('Manager to the Offer') has submitted to the Exchange a copy of Post offer advertisement in accordance with Regulation 18(12) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended, for the attention of the public shareholders of the Company. | Download

Cash Dividend 
Ex. DateOct 29, 2021

Interim • Div/Share: ₹ 4

See all events